← Back to headlines
Jefferies Downgrades Amphastar Pharmaceuticals
Jefferies has downgraded Amphastar Pharmaceuticals (AMPH), citing a lack of meaningful upside catalysts as the reason for its revised rating.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
